Local News: Wantagh, NY 

 | 

Sign Up

 | 

Sign In

Advertisment

Endo Pharmaceuticals Holdings

Endo Pharmaceuticals Holdings News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Endo Pharmaceuticals Holdings News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Endo Pharmaceuticals Holdings News

News on Endo Pharmaceuticals Holdings continually updated from thousands of sources around the net.

Monday | About.com

Testosterone Boosters: Big with Boomers

FDA concerns about the safety of two testosterone boosters from Endo Pharmaceuticals may delay their approval, but safety concerns haven't kept testosterone sales from increasing 25 percent in the past year , according Business Week .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Erectile Dysfunction, Health

Sat Nov 07, 2009

BioSpace

RXi Pharmaceuticals Appoints as CEO

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference , today announced that Noah D. Beerman has joined the company as its new President and Chief Executive Officer.

Comment?

Related Topix: Biotech, Medicine, Indevus Pharmaceuticals, Healthcare Industry

Fri Nov 06, 2009

Bioscience Technology

Bioniche Life Sciences Q1 loss widens to $6.8M from $3.3 as sales dip

Bioniche Life Sciences Inc.'s first-quarter loss more than doubled as revenues slightly dipped, the biotechnology company said Friday.

Comment?

Related Topix: Canada, Biotech, Medicine, Healthcare Industry

Medical News

Bioniche Life Sciences announces financial results for its Fiscal 2010 first-quarter

Bioniche Life Sciences Inc. , a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its Fiscal 2010 first quarter, ended September 30, 2009.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, bladder cancer, Health

Thu Nov 05, 2009

The Biotech Stock Blog

Penwest Pharmaceuticals Co. Q3 2009 Earnings Call Transcript

Penwest Pharmaceuticals Co. November 5, 2009 11:00 am ET Executives Jennifer Good - President and CEO Frank Muscolo - Corporate Controller and Chief Accounting Officer Analysts David Watson Scott Henry - Roth Capital Presentation Operator At this time, I would like to welcome everyone to the Penwest third quarter 2009 financial results conference ...

Comment?

Related Topix: Biotech, Medicine, Penwest Pharmaceuticals, Healthcare Industry

Fri Oct 30, 2009

Customer Interaction Solutions

BUYINS.NET: Endo Pharmaceuticals (ENDP) Up After BUYINS.NET Report Predicted Strength After Earnings

BUYINS.NET, www.buyins.net, a provider of unique trading technologies, released a report on October 27, 2009 at 10:32 am PDT stating that Endo Pharmaceuticals was expected to be higher after its earnings were released before the open on Thursday, October 29, 2009.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets

Thu Oct 29, 2009

BusinessWeek

Testosterone Is Sure Looking Virile

When Endo Pharmaceuticals acquired two experimental testosterone products earlier this year, CEO David P. Holveck predicted that safety issues might delay approval by the U.S. Food & Drug Administration.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Healthcare Law, Food and Drug Administration, Law, Fatigue, Health, Marketing

Tue Oct 27, 2009

Drugs.com

Endo Pharmaceuticals Gives Update on Regulatory Status of Fortesta

Endo Pharmaceuticals today announced that it received a Complete Response letter from the U.S. Food and Drug Administration regarding the New Drug Application for Fortesta 2% Gel for men diagnosed with low testosterone , also known as hypogonadism.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Food and Drug Administration, Health, Pain, Prostate Cancer, Arthritis

Wed Oct 21, 2009

The Herald

Drug approval delay causes ProStrakan dip

Shares in ProStrakan, the Borders-based speciality pharmaceutical group, plunged almost 5% yesterday after it emerged US health regulators delayed approval of its cure-all for the male menopause.

Comment?

Related Topix: World News, United Kingdom, The Scottish Borders County, Scotland, Biotech, Medicine, Healthcare Industry

Tue Oct 20, 2009

Philadelphia Business Journal

Endo to respond to Fortesta questions

Endo Pharmaceuticals said Monday it expects to respond to the Food and Drug Administration's questions about the company's new drug application for the low testosterone treatment Fortesta by mid-2010. Fortesta is an experimental gel product for men diagnosed with low testosterone, also known as hypogonadism.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Chadds Ford, PA

Sun Oct 11, 2009

American Chronicle

News and FDA Updates for Endo

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Comment?

Related Topix: Healthcare Law, Law, Food and Drug Administration, Biotech, Medicine, Healthcare Industry, Opinion

Wed Oct 07, 2009

Freshnews

Pennsylvania Bio Adds Two New Members to Its Board of Directors

Pennsylvania Bio , the statewide Association representing Pennsylvania's biosciences community, today announced the appointment of two new members to its Board of Directors: Dr.

Comment?

Related Topix: Pennsylvania, Biotech, Medicine, Healthcare Industry, University of Pittsburgh, Forest Labs

Sat Oct 03, 2009

Barron's

New Beginnings for Endo Pharma

Endo Pharmaceuticals By Jefferies & Co. WE ARE ASSUMING coverage of Endo Pharmaceuticals from Jefferies analyst David Windley with a Buy rating and a $30 price target.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Solar Energy, Alternative Energy, Renewable Energy (Green Energy), Energy

Fri Sep 11, 2009

Drug Store News

Endo introduces bladder cancer treatment

CHADDS FORD, Pa. Drug maker Endo Pharmaceuticals announced the introduction of a drug that it says fills an unmet need as a treatment for bladder cancer.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Cancer, Health, bladder cancer, Chadds Ford, PA

Tue Sep 08, 2009

PR-inside.com

SADIF Analytics releases new summary due diligence report for Endo Pharmaceuticals

Ilhavo, Portugal a ' 08-09-2009 a ' SADIF Investment Analytics, announces a new summary due diligence report covering Endo Pharmaceuticals .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Sat Sep 05, 2009

Medical News

Endo Pharmaceuticals launches VALSTAR for treating recurrent carcinoma in situ bladder tumors

VALSTAR represents a new treatment option for these patients who may otherwise have exhausted all other FDA-approved treatment alternatives, including BCG.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Healthcare Law, Law, bladder cancer, Health

Fri Sep 04, 2009

Pharmaceutical Processing

FDA Extends Review of Endo's Testosterone Drug Candidate by 3 Months

The FDA extended its review period to Dec. 2. The review had been scheduled to end Sept.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Hypogonadism, Health

Thu Sep 03, 2009

Medical News Today

Endo Pharmaceuticals Gives Update On Regulatory Status Of...

Main Category: Endocrinology Also Included In: Regulatory Affairs / Drug Approvals ; Pharma Industry / Biotech Industry Article Date: 03 Sep 2009 - 3:00 PDT Endo Pharmaceuticals announced that it has been informed by the U.S. Food and Drug Administration that the agency has extended its review period for its long-acting testosterone undecanoate ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Endocrinology, Food and Drug Administration, Health, Pain, Marketing, Prostate Cancer

Wed Sep 02, 2009

TheStreet.com

Endo Drug Faces FDA Decision Wednesday

Drug stock catalyst junkies take note: Tomorrow the U.S. Food and Drug Administration is expected to issue an approval decision on Endo Pharmaceuticals' long-acting injectable testosterone drug, Nebido.

Comment?

Related Topix: Food and Drug Administration, Biotech, Medicine, Healthcare Industry

Tue Sep 01, 2009

TheStreet.com

Endo Drug Faces FDA Decision

A panel of cancer experts convened by the Food and Drug Administration is meeting right now outside Washington, D.C. to review a leukemia drug from biotech firm Genzyme .

Comment?

Related Topix: Healthcare Law, Food and Drug Administration, Law, Biotech, Medicine, Healthcare Industry, Leukemia, Health, Genzyme General, Business News

Wantagh Jobs

Also on Topix